NARMC Starts Monoclonal Antibody Treatment to Reduce Hospitalizations for COVID-19

North Arkansas Regional Medical Center in Harrison begins treatments to reduce hospitalizations for COVID-19.

Monoclonal Antibody Treatments, as defined by the Food and Drug Administration, consists of laboratory-made proteins that mimic the immune system's ability to fight off harmful pathogens such as viruses.

Sammie Cribs, North Arkansas Regional Medical Center’s Chief Operating Officer and Chief Nursing Officer, tells Ozarks First that the hospital has started to use the treatments on COVID-19 patients to lower the number of hospitalizations due to the virus. Cribbs says 258 doses were given in July and only 3% of those ended up being hospitalized. The treatment can be used for COVID patients age 12 or over who have exhibited mild-to-moderate symptoms for less than 10 days according to Cribs. 

More information including a feature story from KOLR-10 can be seen on the Ozarks First Website.